We aim to establish a new standard in living tissue manufacturing by enabling users, researchers and clinicians, to design and bioprint tissues with cellular resolution.
With this commercial launch, we truly want to provide tissue engineering stakeholders with new bioprinting solutions covering all needs, from research in biology and bioengineering to the production of clinical batches.
This new bioprinting platform NGB offers promising pespectives as the clinical and industrial applications of regenerative medecine are growing, when conventional methods of tissue engineering are still limited regarding standardization of manufacturing processes and in the functionality of tissues produced.
Indeed, largely inspired by the principles of the 4.0 Industry, this new platform integrates automation and robotics technologies, coupled with numerous online sensors - including cell microscopy - and Artificial Intelligence processing. In addition, it now integrates all bioprinting techniques (laser, extrusion, inkjet by micro-valve), a world's first in the bioprinting market.
The NGB-R platform
NGB-R is a new generation, multimodal and high-end, 4D bioprinting system developed and designed specifically for tissue engineers, researchers and biologists.
Combining laser-assisted, micro-valve and extrusion bioprinting, it enables true versatility of bioprinting (from cell to spheroids) and offers the possibility of using a large number of biomaterials and hydrogels.
NGB-R includes an embedded microscope for in-line cell printing monitoring and relies on a complete software suite for managing bioprinting protocols, from biological CAD to data analysis of manufacturing.
Fill the form below and receive the latest news about Poieskin straight to your mailbox
You can contact us at email@example.com and we will get in touch with you.